Picking ponies is way easier than picking stocks IMO.

Welcome to the board Dale. You won't have to push threads to the top over here due to a barrage of crap from the idiots on Yahoo!

While I agree with your sentiment, despite the dilution I am hard pressed to find a better long term opportunity than MannKind. I have long said please approve this drug and let the market decide what it is worth. Once money starts flowing from Afrezza, sales all of the other gems in the pipeline (and I am sure some we don't even know about) can start to really aggressively be developed. The drug identifying process Alfred Mann has created within the company should insure innovative drugs as far as the eye can see.